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ABSTRACT
Objective: the different clinical and laboratory features and response to treatment of patients with 
acute brucellar epididymo-orchitis (BEO) reporting to the reference hospital in Southeastern Anato-
lia of Turkey. Material and methods: in this study, 27 male patients with brucellosis, who presented 
with epididymitis or epididymo-orchitis (EO) at the university hospital in Diyarbakir from 1998 to 
2006, were included. They were compared with the other male patients. Positive blood culture or 
high agglutination titers of ≥ 1/160 and positive clinical manifestations of brucellosis were the main 
criteria for diagnosing brucellosis. Results: fourteen patients had unilateral EO. Leukocytosis was 
present in 10 patients; all of them had initial agglutination titers of ≥ 1/160 and 10 patients had a posi-
tive blood culture. All patients received combined therapy with streptomycin for the first 21 days (or 
oral rifampicin for 6-8 weeks) with doxycycline or tetracycline for 6-8 weeks. All showed improvement, 
fever subsided in 3-7 days, and the scrotal enlargement and tenderness regressed. Only one patient 
had a relapse within one year. Conclusion: in brucellosis-endemic areas, clinicians encountering EO 
should consider the likelihood of brucellosis. In this study, young age was the most common risk fac-
tor, and leukocytosis and high CRP level were the most common laboratory findings. Most cases were 
unilateral. All patients responded to medical management very well. Conservative management with 
combination antibiotic therapy was adequate for managing BEO. Conclusively, brucellosis must be 
considered as a cause of orchitis, especially in endemic regions like Turkey.
Keywords: epididymo-orchitis, brucellosis, Turkey, medical treatment.
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Brucellar epididymo-orchitis in southeastern 
part of Turkey: an 8 year experience
INTRODUCTION
Brucellosis is a zoonosis widely distributed 
worldwide. Millions of individuals are at risk 
throughout the world, especially in developing 
countries in which infection in animals is not 
under control. Although the current incidence 
of brucellosis in developed countries is low, it 
occurs sporadically in occupationally exposed 
groups, including farmers, veterinarians, and 
laboratory and slaughterhouse workers.1,2
Brucellosis is an endemic disease in Turkey. 
The incidence of this disease in our country is 
23 per 100,000 yearly.3 It is frequent especially 
in the rural areas of the middle and south-
eastern regions, and Brucella melitensis is the 
most prevalent strain.4 The disease typically 
attacks young and middle-aged adults, with 
a low incidence among infants and elderly 
patients.5 It has high degree of morbidity for 
humans, and has caused significant economic 
loss, representing a serious public health prob-
lem in many developing countries.6
In humans, brucellosis behaves as a system-
ic infection with a very heterogeneous clini-
cal spectrum. The most frequent symptoms 
are fever, chills or rigors, malaise, generalized 
ache, headache, and fatigue. The prevalence 
and pattern of complications depend on strain 
of brucella infecting the individual, age of the 
patient, and duration of disease.7 Gastrointesti-
nal, skeletal, cardiovascular, genitourinary, and 
hematological manifestations are well known. 
Neurobrucellosis, peritonitis, pericarditis, and 
pancytopenia are unusual manifestations of 
brucellosis.8,9 If the disease is not well recog-
nized and not included in the differential diag-
nosis, a treatable disease will be missed.9
In men, various genitourinary infections 
including epididymo-orchitis (EO), prostatitis, 
cystitis, pyelonephritis, interstitial nephritis, 
exudative glomerulonephritis, renal and tes-
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ticular abscess, and seminal vasculitis have been attributed 
to brucellosis. The most frequent genitourinary compli-
cation of brucellosis is EO, affecting 2-20% of males with 
brucellosis,10-12 and it was first described by Hardy as a cause 
of granulamatous orchitis in 1928.13,14 The testes or epidi-
dymis is infiltrated with lymphocytes and plasma cells, and 
there is an atrophy of the seminiferous tubules.8 Although 
the prognosis of brucellar epididymo-orchitis (BEO) is usu-
ally good, delay in diagnosis or inappropriate management 
may result in serious complications, such as testicular ab-
scess, which may require orchiectomy.10
In the present study, the clinical characteristics, treat-
ment, and final outcomes of 27 patients with BEO are pre-
sented and compared with male patients without EO.
MATERIAL AND METHODS
This study was retrospectively carried out at Dicle Uni-
versity Medical Faculty Hospital, Department of Infec-
tious Disease and Clinic Microbiology, between Janu-
ary 1998 and December 2006. Our hospital is the largest 
(1090 beds) in the city of Diyarbakir in the southeastern 
Anatolia region of Turkey.
Definitive diagnosis of brucellosis was made by isolation 
of Brucella spp. from blood cultures. In the absence of positive 
blood culture, presumptive diagnosis was made serologically 
by positive serum standard tube agglutination test together 
with compatible clinical signs and symptoms of brucello-
sis, such as fever, sweating, arthralgia, hepatomegaly, and 
splenomegaly.8 Among these patients with brucellosis, the 
diagnosis of epididymitis or EO was based on clinical symp-
toms (scrotal enlargement, swelling, pain or tenderness not 
due to other causes), and ultrasonographic examination. 
Significant titers were determined to be a Wright’s ag-
glutination ≥ 1/160. The following protocol was followed 
for blood cultures. Two samples of blood (10 mL each) 
were inoculated into BACTEC bottles and incubated in 
the non-radiometric semiautomatic BACTEC 9240 sys-
tem (Becton-Dickinson, Diagnostic Instrument Systems, 
USA) for 30 days. When a positive bottle was detected, a 
Gram stain of the broth was performed, and a portion of 
the fluid was cultured again onto 5% sheep blood, bru-
cella and eosin-methylene blue agar. These subcultures 
were incubated at 37o C in 5% CO
2
 atmosphere for 24-72 
hours. Smears from colonies that grew were stained with 
Gram stain. The isolates of Gram-negative coccobacilli 
were identified with use of conventional biochemical tests 
(e.g., motility; oxidase, catalase, and urease tests; effect 
to glucose and production of H
2
S), and Sceptor system 
(Becton-Dickinson, Maryland, USA).
Mumps, testicular malignancies, and other bacterial 
infections were excluded by: absence of history of paro-
titis, genitourinary tract disease and manipulation, ure-
thral discharge, and sexual exposure; normal serum amy-
lase, lipase, alpha-fetoprotein and beta human chorionic 
gonadotropin levels and negative scrotal ultrasonographic 
findings compatible with testis tumor.
Based on the systemic disease duration from the be-
ginning to admission to hospital, patients were classified 
as acute (less than two months), subacute (2-12 months) 
and chronic (>12 months).16 Age, duration of symptoms 
at admission, history of ingestion of raw milk or milk 
products, clinical symptoms, results of physical examina-
tion, laboratory results, antibiotics administered, and the 
duration of treatment were recorded. In addition, white 
blood cell count (WBC), erythrocyte sedimentation rate 
(ESR), rheumatoid factor (RF), C-reactive protein (CRP), 
blood chemistry profile, and urine analysis were per-
formed in all patients.
Several approaches were used for treatment in these 
patients: Tetracycline (500 mg/6h PO) or doxycycline (100 
mg/12h PO) for 45 days plus streptomycin 1g/day IM) for 
the first 21 days. Doxycycline (100 mg/12h PO) plus ri-
fampicin (15 mg/kg PO) for 45 days. We used both of them 
in treatment of our patients.
Patients were followed up fortnightly until the end of the 
treatment period, monthly for three months, and thereafter 
every three months for one year. Relapse was assessed by a 
recurrence of symptoms and signs of the disease, a positive 
blood culture or rising antibody titer after treatment, in the 
absence of re-exposure to infection.
Data obtained were analyzed using the Statistical Pack-
age for the Social Science (SPSS) for Windows, version 11.0 
software (SPSS, Chicago, IL, USA). Student’s t-test was 
applied for comparison of means and chi-square test for 
comparison of proportions. A p value of < 0.05 was ac-
cepted as significant.
RESULTS
In this study, 302 patients with brucellosis (159 female, 143 
male) were analyzed, 27 of them had EO, giving an incidence 
of EO among males with brucellosis of 18.8%. The clinical 
characteristics, treatment, and final outcomes of 27 patients with 
BEO are compared with male patients without EO (n = 116). 
The mean age of patients with BEO and without EO was 
28 ± 8 years (range, 16-46) and 36 ± 14 years (range, 17-74), 
respectively. This was statistically significant (p = 0.005). 
Of the 27 patients with BEO, 51.7% lived in rural areas and 
48.3% were of urban origin.
An epidemiologic and clinical characteristic of patients 
with and without EO is shown in Table 1. The presum-
able infection source could be identified in 78% of patients 
with BEO and 84% of patients without EO. The possible 
source of infection was that the patients had consumed un-
pasteurized dairy products, especially raw milk and fresh 
cheese, and had direct contact with animals or working 
with animal products obtained from either sheep or goats. 
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Table 1. Epidemiologic and clinical characteristics of patients with and without BEO
 Patients with BEO Patients without BEO
Variable (n = 27) (n = 116) p value
  n (%) n (%)  
Mean age (year) ± SD 28.26 ± 8.42 36.39 ± 14.24 0.005
Clinical type   0.285
Acute 22 (81.8) 77 (66.4)  
Subacute 4 (14.8) 27 (23.2)  
Chronic 1 (3.7) 12 (10.4)  
Mean admission time (day) ± SD 11.78 ± 7.28 10.23 ± 5.89 0.244
History    
Ingesting raw milk/ Fresh cheese 21 (77.7) 90 (77.5) 0.983
Ingesting raw meat balls 4 (14.8) 26 (22.4) 0.382
Animal contact 2 (7.4) 20 (17.2) 0.202
Family history brucellosis 2 (7.4) 14 (12) 0.489
Laboratory workers 0 3 (2.5) 0.398
Unknown transmission 6 (22.2) 18(15.5) 0.401
Symptoms    
Abdominal pain 25 (92.5) 14 (12) < 0.0001
Fever 24 (88.8) 102 (87.9) 0.890
Malaise/ Weakness 22 (81.4) 78 (67.2) 0.146
Arthralgia 20 (74) 99 (85.3) 0.158
Myalgia 19 (70.3) 90 (77.5) 0.428
Sweating 19 (70.3) 86 (74.1) 0.690
Lumbar pain 17 (62.9) 88 (75.8) 0.172
Chills 16 (59.2) 84 (72.4) 0.179
Lack of appetite 13 (48.1) 92 (79.3) 0.001
Headache 10 (37) 71 (61.2) 0.022
Vomiting 4 (14.8) 23 (19.8) 0.549
Rash 2 (7.4) 17 (14.6) 0.318
Jaundice 1 (3.7) 17 (14.6) 0.122
Cough 1 (3.7) 18 (15.5) 0.103
Constipation 1 (3.7) 21 (18.1) 0.062
Depression 1 (3.7) 1 (0.8) 0.257
Diarrhea 0 4 (3.4) 0.328
Scrotal pain 27 (100) 0  
Scrotal redness 24 (88.8) 0  
Scrotal swelling 21 (77.7) 0  
Dysuria 6 (22.2) 0  
Frequent urination 2 (7.4) 0  
Haematuria 1 (3.7) 0  
Signs    
Hepatomegaly 6 (22.2) 32 (27.5) 0.570
Splenomegaly 4 (14.8) 28 (24.1) 0.295
Lymphadenopathy 2 (7.4) 13 (11.2) 0.562
Meningitis 0 8 (6.8) 0.160
Pleural effusion 0 5 (4.3) 0.272
Carditis 0 3 (2.5) 0.398
Usage of antibiotic before admission 10 (37) 29 (25) 0.621
(SD: standard deviation)
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No source was identified in six patients (22.2%) with BEO and 
18 patients (15.5%) without EO. When the distribution of all 
cases was examined according to months of the year, an increase 
was seen in May (Figure 1). There were no significant differences 
in the distribution of months among any of them.
Of the 27 patients with BEO, the onset of symptoms 
was acute in 22 patients (81.8%), subacute in four patients 
(14.8%), and chronic in one patient (3.7%). The mean ad-
mission time was 11.8 ± 7.3 days in patients with BEO and 
10.2 ± 5.9 days in patients without EO, which is not statis-
tically significant (p = 0.244). The symptoms reported at 
admission are shown in Table 1. None of the patients was 
asymptomatic. Fever, scrotal pain and swelling, and scrotal 
redness were the most common symptoms. Headache, lack 
of appetite, abdominal pain were seen in patients with BEO 
more than without EO (p = 0.022, p = 0.001, p < 0.0001 
respectively). Urinary symptoms (dysuria, haematuria, fre-
quency or urgency) were seen in six patients (22.2%).
Laboratory findings of patients are shown in Table 2. ESR, 
WBC, and CRP levels were measured in all patients. ESR 
ranged from 9-81 mm/h (median, 44 mm/h), 25 patients 
(92.9%) had ESR > 20 mm/h and two had ESR < 20 mm/h. 
CRP levels were high (mean 71 ± 21.7 mg/dL; range, 9-140 
Table 2. Hematological findings of patients with and without BEO
 Patients with BEO Patients without BEO
Variable (n = 27) (n = 116) p value
  n (%) n (%)  
WBC /mm3   < 0.0001
 <4600 2 (7.4) 22 (19)  
 4600-10200 15 (55.6) 84 (72.4)  
 10200< 10 (37) 10 (8.6)  
Hematocrit <37.7g/dL 10 (37) 40 (34.5) 0.802
Platelet < 142000 6 (22.2) 26 (22.4) 0.983
ALT > 45 IU/L 9 (33.3) 42 (36.2) 0.779
AST > 45 IU/L 8 (29.6) 41 (35.3) 0.573
GGT > 80 IU/L 4 (14.8) 10 (8.6) 0.329
ALP > 279 IU/L 5 (18.5) 23 (19.8) 0.877
Total bilirubin > 1.2mg/dL 8 (29.6) 22 (19) 0.220
Ferritin > 220ng/mL 7 (25.9) 28 (24.1) 0.846
CK > 226 IU/L 1 (3.7) 9 (7.8) 0.457
ESR > 20mm/h 25 (92.6) 16 (13.8) 0.368
CRP > 8mg/dL 26 (96.3) 87 (75) 0.014
Positive RF 1 (3.7) 7 (6.3) 0.538
Positive blood culture 10 (37) 42 (36.2) 0.936
Positive urine culture 0 0  
(ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALP: alkaline phosphatase,
GGT: γ-glutamyl transpeptidase, CK: creatine kinase, RF: rheumatoid factor)
Figure 1: Distribution of BEO by months of the year.
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mg/dL) in 26 patients with BEO. Leukocytosis (≥ 10200 
WBCs/mm3) was found in 10 patients (37%) and leucope-
nia (< 4600 WBCs/mm3) in two patients (7.4%). Throm-
bocytopenia (< 142000 platelets/mm3) was discovered in 
six patients (22.2%). Urine analysis was available before 
Brucellar epididymo-orchitis
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treatment in all cases; in six, the analysis was abnormal. All 
patients underwent the Rose-Bengal test; the results were 
positive for all of them. Also standard tube agglutination 
testing of initial samples was carried out in all patients and all of 
them were positive for brucella antibodies (titer, ≥ 1/160). 
Two or more blood cultures were drawn under ideal condi-
tions in 17 patients (62.9%). Cultures of blood specimens 
from 10 (37%) of the 27 patients with EO were positive for 
Brucella spp. and 12 patients with negative blood cultures 
had received antibiotic therapy previously. Routine urine 
cultures were taken from all patients in order to rule out 
other genitourinary infections. No growth was detected in 
urine cultures.
When we compared clinical and laboratory findings of 
the patients; young age, high CRP level, and leukocytosis 
were statistically significant (p = 0.005, p= 0.014, p < 0.0001 
respectively).
Scrotal ultrasonography was performed on all patients. 
Of the 27 patients, 14 patients (51.8%) had unilateral in-
volvement of testis and epididymis, seven patients had uni-
lateral involvement of testis and only four had unilateral 
involvement of epididymis. Two patients had bilateral in-
volvement. Testis enlargement was found in 10 patients, and 
six presented hydrocele. Increased vascularization was de-
tected in 22 patients (81.8%).
All patients received combined antibiotic therapy. Be-
fore the diagnosis of BEO, four patients (14.8%) were treat-
ed with different antimicrobial treatments. Eight patients 
(29.6%) had been given antibiotic for brucellosis before 
admission. Once the diagnosis was correctly established, all 
the patients were treated for 45 days. Duration of therapy 
varied according to clinical response and the presence of fo-
cal disease. A total of 16 patients (59.2%) received a combi-
nation of orally administered doxycycline (200 mg/day) for 
6-8 weeks plus streptomycin (1 g/day) for the initial 21 days. 
Eleven patients (40.8%) received a combination of doxycy-
cline (200 mg/day) plus rifampicin (600-900 mg/day) for 
6-8 weeks. There was an improvement in all patients; the 
fever subsided in 3-7 days, and there was local regression of 
the scrotal enlargement. 
For the 20 patients who were admitted as inpatients, the 
median duration of hospital stay was 9.1 ± 4.2 (range, 5-21) 
days; most (17 patients, 62.9%) stayed for 6-10 days and 
four patients (14.8%) had a hospital stay of > 10 days. Or-
chiectomy was not required for any of the patients. Relapse 
occurred in one patient who was discontinuing his therapy.
DISCUSSION 
The incidence of brucellosis has increased during recent 
years due to the inability to complete its eradication among 
the animals of Turkey, especially sheep and goats.4 In our re-
gion the most common etiological agent for brucellosis is B. 
melitensis.17 Our hospital is located in southeastern Anatolia 
of Turkey, where the majority of the population usually con-
sumes unpasteurized dairy products collected from villages. 
Human brucellosis is diagnosed on the basis of epide-
miological and clinical findings, and bacteriological and se-
rological tests. Symptoms of the disease may mimic many 
of the disease and show varied manifestations of acute and 
chronic infection. Complications of brucellosis sometimes 
may lead to misdiagnosis.
Genitourinary involvement is rare and EO is one of the 
manifestations of brucellosis. Brucellosis is a relatively com-
mon cause of BEO in geographic areas where B. melitensis is 
endemic.18 The incidence of BEO is estimated at 2-20%.10,11,14 
In the endemic regions this rate is high,14,19 Khan et al.20 
reported that 35% of the cases of EO in their series were 
caused by brucellosis. Patil et al.21 reported a rate of 6% and 
the studies from Turkey reported that the rate was 5.5% and 
12.7% in their series, respectively.18,22 In another study Khan 
investigated 100 patients with brucellosis and found a rate 
of 6%.23 In the present study, EO occurred in 8.9% of all 
patients and in 18.8% of the male patients with brucellosis. 
This result was similar to that reported by others.22-24
When the distribution of cases according to the months 
of the year was examined, an increase was seen in the spring 
and summer months, possibly due to increased consump-
tion of milk and fresh cheese in spring. Several studies have 
reported a seasonal variation in brucellosis in Turkey.4,17 As 
can be seen in Figure 1, of the 27 patients with BEO, 77.7% 
were seen in spring and summer.
Brucellosis can occur at any age but the most common 
age group involve adolescents and young adults.12,17 In the 
present study, the mean age of patients with EO was 28.2 
years and they were significantly younger than the patients 
without EO, and this was similar with other studies.11,13,14,20,22 
It appears that BEO occurs most commonly in young males. 
This result clearly shows how the age range reflects the mag-
nitude of the socio-economic and cultural impact of brucel-
losis in our region and in Turkey.
Most of our patients (81.8%) had an acute brucel-
losis when EO occurred and this was similar with other 
studies,11,13,22 except one.25 Scrotal pain and swelling, scrotal 
redness and fever were the most common symptoms and 
these were similar to the literature.11,13,20,22,25 Urinary symp-
toms were seen in 22.2% of our patients, this rate was 31% 
in Colmenero et al.,2 47% in Akinci et al.,22 and 69% in 
Kahn et al.20 studies. On the other hand, the rate was lower 
in other studies.10,11,13,25
Abnormal blood test results are usually mild and non-
specific. The hemoglobin level may be lower as a result of 
prolonged infection, and a moderately elevated ESR is found 
in most cases. Liver function tests disclose a mild to moderate 
increase in the hepatic transaminases serum levels.11 Leu-
kocytosis and high CRP levels are the significant labora-
tory findings in our study. Leukocytosis has been usually 
reported as not being a typical feature of brucellosis, but 
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it was presented as an important feature of BEO in some 
studies.20,26 On the other hand, leukocytosis was detected 
at lower rates in some studies.10,13,22 High CRP level is also 
significant in Akinci et al. study.22 However, as far as we 
know, no studies have investigated CRP level except this 
study in the literature. 
Since most patients had used antibiotics effective on 
brucella infection before they were admitted to our hos-
pital, the rate of isolation of microorganism from blood 
culture was found to be low. Only 37% of our patients had 
positive culture for Brucella spp., mostly being B. meliten-
sis. This rate was similar to Yurdakul et al.10 study, but lower 
than the other studies.2,11,22,24
This study was not designed to analyze the ultrasound 
features of BEO but ultrasonography plays an important 
role in the diagnosis, assessment, and management of pa-
tients.26 It is useful to enable the exclusion of the possibility 
of abscess or tumor before establishing the primary clinical 
diagnosis. Unilateral EO is the most common genitourinary 
complication of brucellosis. Infection that is limited to the 
testis is rare; the epididymis is usually involved in patients 
who have acute inflammation. Of the 27 patients, 92.5% had 
unilateral involvement and most of them had EO. This result 
were compatible with the literature.11,13,14,20,22,27,28
The percentage of therapeutic failure or relapse ranges 
from 0% to 40%10,11,13,20 and the need for orchiectomy from 
0% to 5.1%.10,11,13,24 The overall percentage of therapeutic 
failure or relapse in the present study was 3.7%, with no 
patient requiring surgery. Our results were similar to the 
literature. On the other hand, we did not find significant 
differences in the rate of therapeutic failure or relapse be-
tween the patients treated with doxycycline plus strepto-
mycin and those treated with doxycycline plus rifampicin, 
as in the other studies.2,11
CONCLUSION
The frequency of brucella complications is variable in dif-
ferent age groups in Turkey. The most frequent complica-
tion of brucellosis is osteoarticular, followed by cutaneous, 
genitourinary, nervous, and other complications. Brucellosis 
must be considered as a cause of orchitis in especially en-
demic regions like Turkey. Unilateral EO is the most com-
mon genitourinary complication and most of the cases oc-
cur between the second and third decade. Headache, lack of 
appetite, abdominal pain, leukocytosis and high CRP levels 
are the significant findings. All patients respond to medical 
management very well.
Since brucellosis is a preventable disease, knowledge 
and early diagnosis of the complications are especially 
important. Therefore, population education and medical 
precautions are necessary to prevent the harmful effects 
of brucella and its complications. In addition, primary 
health care physicians in endemic regions must recognize 
that brucellosis is an infection which may involve almost 
any organ system and which may vary markedly in its clini-
cal presentation.
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